Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma

Clinical trial NCT00884546 · COMPLETED

Trial details

NCT number: NCT00884546
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer, Various, NOS

Start date: 2009-07-01
Primary completion: 2012-03-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.